Report cover image

Drug-Eluting Stents Market (Material: Metal and Polymer; Drug: Sirolimus, Paclitaxel, Zotarolimus, Everolimus and Others; Application: Coronary Artery Disease, Peripheral Artery Disease and Others; and End-user: Hospitals, Ambulatory Surgical Centers and

Publisher Transparency Market Research Pvt. Ltd.
Published Apr 11, 2025
Length 205 Pages
SKU # TNPR20062347

Description

Drug-Eluting Stents Market – Scope of Report

TMR’s report on the global drug-eluting stents market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2025 to 2035. The report provides revenue of the global drug-eluting stents market for the period 2019–2035, considering 2025 as the base year and 2035 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global drug-eluting stents market from 2025 to 2035.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the drug-eluting stents market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global drug-eluting stents market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global drug-eluting stents market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global drug-eluting stents market.

The report delves into the competitive landscape of the global drug-eluting stents market. Key players operating in the global drug-eluting stents market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global drug-eluting stents market profiled in this report.

Key Questions Answered in global drug-eluting stents Market Report
  • What is the sales/revenue generated by drug-eluting stents across all regions during the forecast period?
  • What are the opportunities in the global drug-eluting stents market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2035?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?
Drug-Eluting Stents Market – Research Objectives and Research Approach

The comprehensive report on the global drug-eluting stents market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global drug-eluting stents market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2035 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global drug-eluting stents market.

Table of Contents

205 Pages
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Drug-Eluting Stents Market
4. Market Overview
4.1. Introduction
4.1.1. Segment Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Drug-Eluting Stents Market Analysis and Forecast, 2020-2035
4.4.1. Market Revenue Projections (US$ Bn)
5. Key Insights
5.1. Technological Advancements
5.2. PORTER’s Five Forces Analysis
5.3. PESTEL Analysis
5.4. Supply Chain Analysis
5.5. Key Industry Events (Mergers, Acquisitions, Partnerships, Collaborations, etc.)
5.6. Pricing Analysis (Brand pricing, Average Selling Price by Region/Country)
5.7. Regulatory Scenario by Key Country/Region
5.8. Research and Development Trends
5.9. Go-to-Market Strategy for New Market Entrants
6. Global Drug-Eluting Stents Market Analysis and Forecast, by Material
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Material, 2020-2035
6.3.1. Metal
6.3.1.1. Stainless-Steel
6.3.1.2. Cobalt-Chromium
6.3.1.3. Nitinol
6.3.1.4. Others
6.3.2. Polymer
6.3.2.1. Non-biodegradable Polymers
6.3.2.2. Biodegradable Polymers
6.4. Market Attractiveness Analysis, by Material
7. Global Drug-Eluting Stents Market Analysis and Forecast, by Drug
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Drug, 2020-2035
7.3.1. Sirolimus
7.3.2. Paclitaxel
7.3.3. Zotarolimus
7.3.4. Everolimus
7.3.5. Others
7.4. Market Attractiveness Analysis, by Drug
8. Global Drug-Eluting Stents Market Analysis and Forecast, by Application
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by Application , 2020-2035
8.3.1. Coronary Artery Disease
8.3.2. Peripheral Artery Disease
8.3.3. Others
8.4. Market Attractiveness Analysis, by Application
9. Global Drug-Eluting Stents Market Analysis and Forecast, by End-user
9.1. Introduction & Definition
9.2. Key Findings/Developments
9.3. Market Value Forecast, by End-user, 2020-2035
9.3.1. Hospitals
9.3.2. Ambulatory Surgical Centers
9.3.3. Others
9.4. Market Attractiveness Analysis, by End-user
10. Global Drug-Eluting Stents Market Analysis and Forecast, by Region
10.1. Key Findings
10.2. Market Value Forecast, by Region, 2020-2035
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3. Market Attractiveness By Region
11. North America Drug-Eluting Stents Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Material, 2020-2035
11.2.1. Metal
11.2.1.1. Stainless-Steel
11.2.1.2. Cobalt-Chromium
11.2.1.3. Nitinol
11.2.1.4. Others
11.2.2. Polymer
11.2.2.1. Non-biodegradable Polymers
11.2.2.2. Biodegradable Polymers
11.3. Market Value Forecast, by Drug, 2020-2035
11.3.1. Sirolimus
11.3.2. Paclitaxel
11.3.3. Zotarolimus
11.3.4. Everolimus
11.3.5. Others
11.4. Market Value Forecast, by Application , 2020-2035
11.4.1. Coronary Artery Disease
11.4.2. Peripheral Artery Disease
11.4.3. Others
11.5. Market Value Forecast, by End-user, 2020-2035
11.5.1. Hospitals
11.5.2. Ambulatory Surgical Centers
11.5.3. Others
11.6. Market Value Forecast, by Country, 2020-2035
11.6.1. U.S.
11.6.2. Canada
11.7. Market Attractiveness Analysis
11.7.1. By Material
11.7.2. By Drug
11.7.3. By Application
11.7.4. By End-user
11.7.5. By Country
12. Europe Drug-Eluting Stents Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Material, 2020-2035
12.2.1. Metal
12.2.1.1. Stainless-Steel
12.2.1.2. Cobalt-Chromium
12.2.1.3. Nitinol
12.2.1.4. Others
12.2.2. Polymer
12.2.2.1. Non-biodegradable Polymers
12.2.2.2. Biodegradable Polymers
12.3. Market Value Forecast, by Drug, 2020-2035
12.3.1. Sirolimus
12.3.2. Paclitaxel
12.3.3. Zotarolimus
12.3.4. Everolimus
12.3.5. Others
12.4. Market Value Forecast, by Application , 2020-2035
12.4.1. Coronary Artery Disease
12.4.2. Peripheral Artery Disease
12.4.3. Others
12.5. Market Value Forecast, by End-user, 2020-2035
12.5.1. Hospitals
12.5.2. Ambulatory Surgical Centers
12.5.3. Others
12.6. Market Value Forecast, by Country/Sub-region, 2020-2035
12.6.1. Germany
12.6.2. UK
12.6.3. France
12.6.4. Italy
12.6.5. Spain
12.6.6. Rest of Europe
12.7. Market Attractiveness Analysis
12.7.1. By Material
12.7.2. By Drug
12.7.3. By Application
12.7.4. By End-user
12.7.5. By Country/Sub-region

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us